A compound of formula I is described:
which showed to be surprisingly and significantly effective as an allosteric modulator of the AMPA receptor and is therefore particularly suitable for the treatment of mnemocognitive disorders ascribable to an alteration of glutamatergic neurotransmission, such as age-related disorders, anxiety, progressive neurodegenerative disorders, depressive disorders, schizophrenia, obsessive-compulsive disorders and bipolar disorder.
描述了一种
化学式为I的化合物:它被发现是一种令人惊讶且显著有效的
AMPA受体异构调节剂,因此特别适用于治疗由谷
氨酸能神经递质传递失调引起的记忆认知障碍,如与年龄相关的障碍、焦虑症、进行性神经退行性疾病、抑郁症、精神分裂症、强迫症和躁狂症。